# [18F]Florbetazine ([18F]92) for Beta Amyloid PET Imaging in Alzheimer's Disease

> **NCT06141356** · — · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 150 (estimated)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** [18F]Florbetazine ([18F]92)
- **DRUG:** [11C]PIB

## Key facts

- **NCT ID:** NCT06141356
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-01-30
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2023-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06141356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06141356, "[18F]Florbetazine ([18F]92) for Beta Amyloid PET Imaging in Alzheimer's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06141356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*